{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:24:44Z","timestamp":1759530284538,"version":"3.40.5"},"reference-count":69,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV"],"DOI":"10.2147\/hiv.s294367","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:41:02Z","timestamp":1623890462000},"page":"667-679","source":"Crossref","is-referenced-by-count":6,"title":["Predictors of Current CD4+ T-Cell Count Among Women of Reproductive Age on Antiretroviral Therapy in Public Hospitals, Southwest Ethiopia"],"prefix":"10.2147","volume":"Volume 13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7039-6600","authenticated-orcid":true,"given":"Alemayehu Sayih","family":"Belay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7666-3375","authenticated-orcid":true,"given":"Gizachew Ayele","family":"Manaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0568-8962","authenticated-orcid":true,"given":"Kindie Mitiku","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3824-7215","authenticated-orcid":true,"given":"Dejene Derseh","family":"Abateneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,6]]},"reference":[{"key":"ref1","unstructured":"UNAIDS. Global HIV & AIDS statistics \u2014 2020 fact sheet. 2020; Available from: https:\/\/www.unaids.org\/en\/resources\/fact-sheet. Accessed November 6, 2020."},{"key":"ref2","unstructured":"AmfAR. Statistics: women and HIV\/AIDS. 2020; Available from: https:\/\/www.amfar.org\/about-hiv-and-aids\/facts-and-stats\/statistics\u2013women-and-hiv-aids\/. Accessed May 13, 2021."},{"key":"ref3","first-page":"288","volume":"12","author":"Charles","year":"2002","journal-title":"AIDS Read"},{"key":"ref4","unstructured":"UNAIDS. UNAIDS country director, Ethiopia - eligibility to apply limited; check additional information*; 2020; Available from: https:\/\/erecruit.unaids.org\/public\/hrd-cl-vac-view.asp?o_c=1000&jobinfo_uid_c=36610&vaclng=en. Accessed June 1, 2021."},{"key":"ref5","unstructured":"UNAIDS. Ethiopia | UNAIDS; 2020. Available from: https:\/\/www.unaids.org\/en\/regionscountries\/countries\/ethiopia. Accessed November 6, 2020."},{"key":"ref6","unstructured":"Health NIo. What is HAART? | National Institute on Drug Abuse (NIDA); 2020. Available from: https:\/\/www.drugabuse.gov\/publications\/research-reports\/hivaids\/what-haart. Accessed November 5, 2020."},{"key":"ref7","unstructured":"CDC. HIV treatment; 2020. Available from: https:\/\/www.cdc.gov\/hiv\/basics\/livingwithhiv\/treatment.html. Accessed May 12, 2021."},{"key":"ref8","unstructured":"World Health Organization. Guideline on when to start antiretroviral therapy on pre-exposure prophylaxis for HIV; 2015. Available from: https:\/\/www.who.int\/hiv\/pub\/guidelines\/earlyrelease-arv\/en\/. Accessed June 1, 2021."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e0220337","DOI":"10.1371\/journal.pone.0220337","volume":"14","author":"Glass","year":"2019","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.15585\/mmwr.mm6547a2","volume":"65","author":"Lecher","year":"2016","journal-title":"Morbid Mortal Wkly Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/cid\/ciw001","volume":"62","author":"Roberts","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref12","unstructured":"World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy, July 2017. 2017."},{"key":"ref13","unstructured":"Foundation EGPA. Advanced HIV disease and opportunistic infection; 2021. Available from: https:\/\/www.pedaids.org\/our-expertise\/advanced-hiv-disease-and-opportunistic-infection\/. Accessed June 1, 2021."},{"key":"ref14","unstructured":"SinoBiological. Cluster of differentiation 4\/CD4. 2021. Available from: https:\/\/www.sinobiological.com\/research\/cd-antigens\/cluster-of-differentiation-4. Accessed May 15, 2021."},{"journal-title":"Update","year":"2017","author":"No","key":"ref15"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1473-3099(14)70896-5","volume":"15","author":"Ford","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1093\/cid\/ciu094","volume":"58","author":"Masur","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref18","unstructured":"World Health Organization. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children. World Health Organization; 2007."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/135965350801302S04","volume":"13","author":"Bennett","year":"2008","journal-title":"Antivir Ther"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12865-018-0278-4","volume":"19","author":"Ayele","year":"2018","journal-title":"BMC Immunol"},{"key":"ref21","first-page":"295","volume":"12","author":"Manaye","year":"2020","journal-title":"HIV\/AIDS (Auckland, NZ)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-016-2182-4","volume":"9","author":"Gezie","year":"2016","journal-title":"BMC Res Notes"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e0226293","DOI":"10.1371\/journal.pone.0226293","volume":"14","author":"Desta","year":"2019","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.9734\/BJMMR\/2014\/8469","volume":"4","author":"Ebonyi","year":"2014","journal-title":"Br J Med Med Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1086\/425075","volume":"190","author":"Smith","year":"2004","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.1468-1293.2003.00156.x","volume":"4","author":"Florence","year":"2003","journal-title":"HIV Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-021-05523-w","volume":"14","author":"Farhadian","year":"2021","journal-title":"BMC Res Notes"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e84276","DOI":"10.1371\/journal.pone.0084276","volume":"9","author":"Montarroyos","year":"2014","journal-title":"PLoS One"},{"key":"ref29","first-page":"115","volume":"7","author":"Akinbami","year":"2015","journal-title":"HIV\/AIDS (Auckland, NZ)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/0956462416650980","volume":"28","author":"Bruneau","year":"2017","journal-title":"Int J STD AIDS"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-016-0119-6","volume":"13","author":"Seyoum","year":"2016","journal-title":"AIDS Res Ther"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/cid\/cit232","volume":"57","author":"Helleberg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref33","unstructured":"CSA. Population and housing census 2007 report, SNNPR, part I: population size and characteristics; 2007 Available from: https:\/\/microdata.worldbank.org\/index.php\/catalog\/2747\/related-materials. Accessed March 21, 2021."},{"key":"ref34","unstructured":"NACO. National guidelines on second-line ART for adults and adolescents. 2013. Available from: http:\/\/naco.gov.in\/sites\/default\/files\/National%20Guidelines%20on%20Second-line%20and%20Alternative%20First-line%20ART%20For%20Adults%20and%20Adolescents%20May%202013_0.pdf. Accessed June 1, 2021."},{"key":"ref35","unstructured":"World Health Organization. March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2014."},{"key":"ref36","volume":"12","author":"Delhi","year":"2011","journal-title":"Curr Epidemiol Situation HIV\/AIDS Ann Rep"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/QAD.0b013e3283262a78","volume":"23","author":"Reynolds","year":"2009","journal-title":"AIDS (London, England)"},{"key":"ref38","first-page":"141","volume":"8","author":"Ayalew","year":"2016","journal-title":"HIV\/AIDS (Auckland, NZ)"},{"key":"ref39","volume":"8","author":"Bokretsion","year":"2017","journal-title":"J AIDS Clin Res"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10461-011-0068-y","volume":"17","author":"Matthews","year":"2013","journal-title":"AIDS Behav"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"350","DOI":"10.2105\/AJPH.2009.177469","volume":"101","author":"Kaida","year":"2011","journal-title":"Am J Public Health"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/13691051003628922","volume":"12","author":"Kisakye","year":"2010","journal-title":"Cult Health Sex"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/1471-2458-11-530","volume":"11","author":"King","year":"2011","journal-title":"BMC Public Health"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e17518","DOI":"10.1371\/journal.pone.0017518","volume":"6","author":"El-Khatib","year":"2011","journal-title":"PLoS One"},{"key":"ref45","volume":"24","author":"Jaka","year":"2009","journal-title":"Tanzan Med J"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-12-197","volume":"12","author":"Bacha","year":"2012","journal-title":"BMC Infect Dis"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-14-468","volume":"14","author":"Assefa","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-04972-1","volume":"20","author":"Dessie","year":"2020","journal-title":"BMC Infect Dis"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ijid.2016.02.589","volume":"45","author":"Maurya","year":"2016","journal-title":"Int J Infect Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/virtualmentor.2010.12.3.cprl1-1003","volume":"12","author":"Weinberg","year":"2010","journal-title":"AMA J Ethics"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1097\/QAD.0b013e32810c8dce","volume":"21","author":"Kagaayi","year":"2007","journal-title":"Aids"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1874431101812010011","volume":"12","author":"Sorsa","year":"2018","journal-title":"Open Med Inform J"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e038741","DOI":"10.1136\/bmjopen-2020-038741","volume":"10","author":"Desta","year":"2020","journal-title":"BMJ Open"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6817325","volume":"2016","author":"Ojha","year":"2016","journal-title":"Biomed Res Int"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/jac\/dkh329","volume":"54","author":"Waters","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1089\/aid.2008.0173","volume":"25","author":"Wang","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2147\/PPA.S26507","volume":"6","author":"Abrogoua","year":"2012","journal-title":"Patient Prefer Adherence"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12879-018-3176-8","volume":"18","author":"Molla","year":"2018","journal-title":"BMC Infect Dis"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"e1745","DOI":"10.1542\/peds.2006-0493","volume":"118","author":"Williams","year":"2006","journal-title":"Pediatrics"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1161\/01.CIR.102.13.1542","volume":"102","author":"Lipshultz","year":"2000","journal-title":"Circulation"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.ahj.2005.07.030","volume":"151","author":"Sudano","year":"2006","journal-title":"Am Heart J"},{"key":"ref62","unstructured":"Buba F. Cardiovascular opportunistic infections in HIV disease. 2011."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hiv.12119","volume":"15","author":"Williams","year":"2014","journal-title":"HIV Med"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/imr.12066","volume":"254","author":"Okoye","year":"2013","journal-title":"Immunol Rev"},{"key":"ref65","unstructured":"Carter M. Any reduction in viral load has immunologic benefits for people with HIV who have triple-class treatment failure; 2013. Available from: https:\/\/www.aidsmap.com\/news\/jan-2013\/any-reduction-viral-load-has-immunologic-benefits-people-hiv-who-have-triple-class. Accessed November 23, 2020."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"e0187566","DOI":"10.1371\/journal.pone.0187566","volume":"12","author":"Fokam","year":"2017","journal-title":"PLoS One"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1056\/NEJM199905273402101","volume":"340","author":"Zhang","year":"1999","journal-title":"N Engl J Med"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/8394","volume":"5","author":"Finzi","year":"1999","journal-title":"Nat Med"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4314\/ejhs.v26i1.6","volume":"26","author":"Kokeb","year":"2016","journal-title":"Ethiop J Health Sci"}],"container-title":["HIV\/AIDS - Research and Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=70636","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=70636","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T12:15:44Z","timestamp":1672488944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/predictors-of-current-cd4-t-cell-count-among-women-of-reproductive-age-peer-reviewed-fulltext-article-HIV"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":69,"URL":"https:\/\/doi.org\/10.2147\/hiv.s294367","relation":{},"ISSN":["1179-1373"],"issn-type":[{"type":"electronic","value":"1179-1373"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}